Media Summary: How Can Data Aggregators Support Specialty Product Launches? Ray Tancredi, RPh, MBA, CSP, vice president of "This overview discusses: - The importance of evaluating the patient journey to develop a deeper understanding of the

With Data Aggregation Where Is The Specialty Pharmaceutical Space Lacking - Detailed Analysis & Overview

How Can Data Aggregators Support Specialty Product Launches? Ray Tancredi, RPh, MBA, CSP, vice president of "This overview discusses: - The importance of evaluating the patient journey to develop a deeper understanding of the David D'Altorio, PharmD, senior vice president of health services at MedImpact Healthcare Systems, discusses how Joseph Morse, president and chief operating officer of Therigy, LLC, discusses how Submit proposed questions on this poster to DMFWorkshop2021.hhs.gov by March 19, 2021, and tune in for the subsequent ...

Paul Sipes, vice president of Spud Software, discusses how In this episode, Subhi breaks down Q11 by focusing on three key sections: how the Kevin James, RPh, MBA, vice president of Payer Strategy at US Bioservices, discusses optimal support for distribution of Find out about multispecific drugs as Ryan Potts, director of the Induced Proximity Platform at Amgen describes how these exciting ...

Photo Gallery

With Data Aggregation, Where is the Specialty Pharmaceutical Space Lacking?
How Can Data Aggregators Support Specialty Product Launches?
How Should Specialty Pharmaceutical Stakeholders, Advocates Collaborate to Create Data Standards?
Data Aggregation in Specialty Pharmacy
Specialty Pharmacy Data Aggregation
What Improvements Are Needed for Data Analytics in the Specialty Pharmaceutical Space?
What Type of Patient Metrics Can Data Aggregators Provide to Manufacturers, Specialty Pharmacies?
Optimal Use of Data Analytics for Specialty Pharmacy
How Can Data be Leveraged to Improve Patient Outcomes?
What is data aggregation in under 2 minutes!
How to Optimize Use of Data Analytics in Specialty Pharmacy
Regulatory Considerations for Synthetic and Semi-synthetic Oligosaccharide Complex APIs in Generics
View Detailed Profile
With Data Aggregation, Where is the Specialty Pharmaceutical Space Lacking?

With Data Aggregation, Where is the Specialty Pharmaceutical Space Lacking?

John Giannouris, vice president,

How Can Data Aggregators Support Specialty Product Launches?

How Can Data Aggregators Support Specialty Product Launches?

How Can Data Aggregators Support Specialty Product Launches?

How Should Specialty Pharmaceutical Stakeholders, Advocates Collaborate to Create Data Standards?

How Should Specialty Pharmaceutical Stakeholders, Advocates Collaborate to Create Data Standards?

John Giannouris, vice president,

Data Aggregation in Specialty Pharmacy

Data Aggregation in Specialty Pharmacy

Ray Tancredi, RPh, MBA, CSP, vice president of

Specialty Pharmacy Data Aggregation

Specialty Pharmacy Data Aggregation

"This overview discusses: - The importance of evaluating the patient journey to develop a deeper understanding of the

What Improvements Are Needed for Data Analytics in the Specialty Pharmaceutical Space?

What Improvements Are Needed for Data Analytics in the Specialty Pharmaceutical Space?

John Giannouris, vice president,

What Type of Patient Metrics Can Data Aggregators Provide to Manufacturers, Specialty Pharmacies?

What Type of Patient Metrics Can Data Aggregators Provide to Manufacturers, Specialty Pharmacies?

John Giannouris, vice president,

Optimal Use of Data Analytics for Specialty Pharmacy

Optimal Use of Data Analytics for Specialty Pharmacy

David D'Altorio, PharmD, senior vice president of health services at MedImpact Healthcare Systems, discusses how

How Can Data be Leveraged to Improve Patient Outcomes?

How Can Data be Leveraged to Improve Patient Outcomes?

John Giannouris, vice president,

What is data aggregation in under 2 minutes!

What is data aggregation in under 2 minutes!

Data aggregation

How to Optimize Use of Data Analytics in Specialty Pharmacy

How to Optimize Use of Data Analytics in Specialty Pharmacy

Joseph Morse, president and chief operating officer of Therigy, LLC, discusses how

Regulatory Considerations for Synthetic and Semi-synthetic Oligosaccharide Complex APIs in Generics

Regulatory Considerations for Synthetic and Semi-synthetic Oligosaccharide Complex APIs in Generics

Submit proposed questions on this poster to DMFWorkshop2021@fda.hhs.gov by March 19, 2021, and tune in for the subsequent ...

Data Warehousing and Specialty Pharmacy

Data Warehousing and Specialty Pharmacy

Paul Sipes, vice president of Spud Software, discusses how

ICH Q11 Explained: Drug Substance & API in 6 Minutes

ICH Q11 Explained: Drug Substance & API in 6 Minutes

In this episode, Subhi breaks down Q11 by focusing on three key sections: how the

Managing Effective Specialty Drug Distribution

Managing Effective Specialty Drug Distribution

Kevin James, RPh, MBA, vice president of Payer Strategy at US Bioservices, discusses optimal support for distribution of

What's So Special About Specialty Pharmacy.  Specialty Pharmacy Explained.

What's So Special About Specialty Pharmacy. Specialty Pharmacy Explained.

What's So Special About

Specialty Pharmacy Data: A Billion-Dollar Question

Specialty Pharmacy Data: A Billion-Dollar Question

Many

API Manufacturing Global Distribution and Facility Profile Analysis

API Manufacturing Global Distribution and Facility Profile Analysis

Submit proposed questions on this poster to DMFWorkshop2021@fda.hhs.gov by March 19, 2021, and tune in for the subsequent ...

Specialty Pharmacy Distribution and Data

Specialty Pharmacy Distribution and Data

Specialty Pharmacy Distribution and Data

What are Multispecific Drugs?

What are Multispecific Drugs?

Find out about multispecific drugs as Ryan Potts, director of the Induced Proximity Platform at Amgen describes how these exciting ...